Catalyst Wire Dossier Catalyst Wire Dossier

Temodar

Temozolomide · Merck & Co
Drug timelines are a Plus or Pro feature.

261 regulatory and trial events tracked for Temodar, covering 2006-10-19 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy [Phase 2]

See pricing